[{"Assets_0_Q2_USD":451646000.0,"CommonStockSharesOutstanding_0_Q2_shares":46416789.0,"EarningsPerShareBasic_2_Q2_USD":-0.22,"EarningsPerShareBasic_1_Q2_USD":-0.06,"EarningsPerShareDiluted_2_Q2_USD":-0.22,"EarningsPerShareDiluted_1_Q2_USD":-0.06,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":12893000.0,"NetIncomeLoss_2_Q2_USD":-10036000.0,"NetIncomeLoss_1_Q2_USD":-2790000.0,"StockholdersEquity_0_Q2_USD":320526000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":46535000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":46557000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":46535000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":46557000.0,"Ticker":"AMPH","CIK":"1297184","name":"AMPHASTAR PHARMACEUTICALS, INC.","OfficialName":"Amphastar Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1905609900.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180809"}]